- Sprache
-
Englisch
- Identifier
-
129474559X
- Beteiligte Personen und Organisationen
- DOI
-
10.3390/ijms140714712
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
24.08.2023, 09:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schwarzenbacher, Daniela
- Balic, Marija
- Pichler, Martin
Ähnliche Objekte (12)
Best of ASCO 2022: bladder cancer
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
Inflammation, phagocytosis and cancer: another step in the CD47 act
Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
RNA-binding proteins as important regulators of long non-coding RNAs in cancer
High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer
MicroRNAs: clinical relevance in colorectal cancer
Involvement of the long noncoding RNA NEAT1 in carcinogenesis
Multi-omics in prognosis of hepatocellular carcinoma
Best of ASCO 2022: bladder cancer
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
Inflammation, phagocytosis and cancer: another step in the CD47 act
Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
RNA-binding proteins as important regulators of long non-coding RNAs in cancer
High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer
MicroRNAs: clinical relevance in colorectal cancer
Involvement of the long noncoding RNA NEAT1 in carcinogenesis
Multi-omics in prognosis of hepatocellular carcinoma
Best of ASCO 2022: bladder cancer
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
Inflammation, phagocytosis and cancer: another step in the CD47 act
Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
RNA-binding proteins as important regulators of long non-coding RNAs in cancer
High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer
MicroRNAs: clinical relevance in colorectal cancer
Involvement of the long noncoding RNA NEAT1 in carcinogenesis